Tea polyphenols regulate nicotinamide adenine dinucleotide phoshate oxidase subunit expression and ameliorate angiotensin II-induced hyperpermeability in endothelial cells

Hypertension Research

Volumn 26, Issue 10, 2003, Pages 823-828

  Ying, Chen Jiang ^a,b   Xu, Jin Wen ^a,c   Ikeda, Katsumi ^a,c   Takahashi, Kyoko ^a   Nara, Yasuo ^c   Yamori, Yukio ^c  

^a MUKOGAWA WOMEN'S UNIVERSITY   (Japan)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c WHO Collaborating Center   (Japan)

Author keywords

Angiotensin II; Endothelial cell permeability; Nicotinamide adenine dinucleotide phosphate oxidase; Tea polyphenols

Indexed keywords

ALPHA TOCOPHEROL; ANGIOTENSIN; BLACK TEA EXTRACT; CATALASE; DIPHENYLIODONIUM SALT; GREEN TEA EXTRACT; POLYPHENOL DERIVATIVE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; SUPEROXIDE;

ANIMAL CELL; ARTICLE; CARDIOVASCULAR DISEASE; CAROTID ARTERY; CELL MEMBRANE PERMEABILITY; CELL STIMULATION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENDOTHELIUM LESION; ENZYME SUBUNIT; ESSENTIAL HYPERTENSION; FLUORESCENCE ANALYSIS; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION; TEA; UPREGULATION; VASCULAR ENDOTHELIUM;

ANGIOTENSIN II; ANIMALS; CAPILLARY PERMEABILITY; CAROTID ARTERIES; CATTLE; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; FLAVONOIDS; MEMBRANE TRANSPORT PROTEINS; NADPH DEHYDROGENASE; NADPH OXIDASE; PHENOLS; PHOSPHOPROTEINS; REACTIVE OXYGEN SPECIES; SUPEROXIDES; TEA; VASOCONSTRICTOR AGENTS;

EID: 0242609907     PISSN: 09169636     EISSN: None     Source Type: Journal    
DOI: 10.1291/hypres.26.823     Document Type: Article

References (45)

1. Zalba G, Jose GS, Moreno MU, et al: Oxidative stress in arterial hypertension: role of NAD(P)H oxidase. Hypertension 2001; 38: 1395-1399.
2. Sharma R, Davidoff MN: Oxidative stress and endothelial dysfunction in heart failure. Congest Heart Fail 2002; 8: 165-172.
3. Stokes K, Cooper D, Tailor A, Granger D: Hypercholesterolemia promotes inflammation and microvascular dysfunction: role of nitric oxide and superoxide. Free Radic Biol Med 2002; 33: 1026-1036.
4. Wassmann S, Hilgers S, Laufs U, Bohm M, Nickenig G: Angiotensin II type 1 receptor antagonism improves hypercholesterolemia-associated endothelial dysfunction. Arterioscler Thromb Vasc Biol 2002; 22: 1208-1212.
5. Sowers JR, Epstein M, Frohlich ED: Diabetes, hypertension, and cardiovascular disease: an update. Hypertension 2001; 37: 1053-1059.
6. Ceriello A, Taboga C, Tonutti L, et al: Evidence for an independent and cumulative effect of postprandial hypertriglyceridemia and hyperglycemia on endothelial dysfunction and oxidative stress generation: effects of short- and long-term simvastatin treatment. Circulation 2002; 106: 1211-1218.
7. Li N, Yi FX, Rute E, Zhang DX, Slocum GR, Zou AP: Effects of homocysteine on intracellular nitric oxide and superoxide levels in the renal arterial endothelium. Am J Physiol Heart Circ Physiol 2002; 283: H1237-H1243.
8. Cai H, Harrison DG: Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res 2000; 87: 840-844.
9. Wassmann S, Laufs U, Stamenkovic D, et al: Raloxifene improves endothelial dysfunction in hypertension by reduced oxidative stress and enhanced nitric oxide production. Circulation 2002; 105: 2083-2091.
10. Droge W: Free radicals in the physiological control of cell function. Physiol Rev 2002; 82: 47-95.
11. Griendling KK, Sorescu D, Lassegue B, Ushio-Fukai M: Modulation of protein kinase activity and gene expression by reactive oxygen species and their role in vascular physiology and pathophysiology. Arterioscler Thromb Vasc Biol 2000; 20: 2175-2183.
12. Kerr S, Brosnan JM, McIntyre M, Reid JL, Dominiczak AF, Hamilton CA: Superoxide anion production is increased in a model of genetic hypertension. Hypertension 1999; 33: 1353-1358.
13. Sagar S, Kallo IJ, Kaul N, Ganguly NK, Sharma BK: Oxygen free radicals in essential hypertension. Mol Cell Biochem 1992; 111: 103-108.
14. Somers MJ, Mavromatis K, Galis ZS, Harrison DG: Vascular superoxide production and vasomotor function in hypertension induced by deoxy-corticosterone acetate-salt. Circulation 2000; 101: 1722-1728.
15. Gonick HC, Ding Y, Bondy SC, Nosratola D: Lead-induced hypertension: interplay of nitric oxide and reactive oxygen species. Hypertension 1997; 30: 1487-1492.
16. Gorlach A, Brandes RP, Nguyen K, Amidi M, Dehghani F, Busse R: A gp91phox containing NADPH oxidase selectively expressed in endothelial cells is a major source of oxygen radical generation in the arterial wall. Circ Res 2000; 87: 26-32.
17. Rueckschloss U, Quinn MT, Holtz J, Morawietz H: Dose-dependent regulation of NAD(P)H oxidase expression by angiotensin II in human endothelial cells: protective effect of angiotensin II type 1 receptor blockade in patients with coronary artery disease. Arterioscler Thromb Vasc Biol 2002; 22: 1845-1851.
18. Brown AA, Hu FB: Dietary modulation of endothelial function: implication for cardiovascular disease. Am J Clin Nutr 2001; 73: 673-686.
19. Laursen JB, Rajagopalan S, Galis Z, Tarpey M, Freeman BA, Harrison DG: Role of superoxide in angiotensin II-induced but not catecholamine-induced hypertension. Circulation 1997; 95: 588-593.
20. Noguchi T, Ikeda K, Sasaki Y, et al: Effects of vitamin and sesamin on hypertension and cerebral thrombogenesis in stroke-prone spontaneously hypertensive rats. Hypertens Res 2001; 24: 735-742.
21. On YK, Kim CH, Oh BH, Lee MM, Park YB: Effects of angiotensin converting enzyme inhibitor and calcium antagonist on endothelial function in patients with essential hypertension. Hypertens Res 2002; 25: 365-371.
22. Mochizuki M, Yamazaki S, Kano K, Ikeda T: Kinetic analysis and mechanistic aspects of autoxidation of catechins. Biochim Biophys Acta 2002; 1569: 35-44.
23. Nijveldt RJ, van Nood E, van Hoorn DEC, Boelens PG, van Norren K, van Leeuwen PAM: Flavonoids: a review of probable mechanisms of action and potential applications. Am J Clin Nutr 2001; 74: 418-425.
24. Hertog MGL, Feskens EJM, Hollman PCH, Katan MB, Kromhout D: Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet 1993; 342: 1007-1011.
25. Arts ICW, Hollman PCH, Feskens EJM, de Mesquita HBB, Kromhout D: Catechin intake might explain the inverse relation between tea consumption and ischemic heart disease: the Zutphen Elderly Study. Am J Clin Nutr 2001; 74: 227-232.
26. Mukamal KJ, Maclure M, Muller JE, Sherwood JB, Mittleman MA: Tea consumption and mortality after acute myocardial infarction. Circulation 2002; 105: 2476-2481.
27. Duffy SJ, Keaney JF Jr, Holbrook M, et al: Short- and long-term black tea consumption reverses endothelial Dysfunction in patients with coronary artery disease. Circulation 2001; 104: 151-156.
28. Suh Y-A, Arnold RS, Lassegue B, et al: Cell transformation by the superoxide-generating oxidase Mox1. Nature 1999; 401: 79-82.
29. Hordijk PL, Anthony E, Mul FP, et al: Vascular-endothelial-cadherin modulates endothelial monolayer permeability. J Cell Sci 1999; 112: 1915-1923.
30. Cosentino F, Volpe M: Antihypertensive effect and end-organ protection of flavonoids: some insights, more questions. J Hypertens 2002; 20: 1721-1724.
31. van Acker FA, Schouten O, Haenen GR, van der Vijgh WJ, Bast A: Flavonoids can replace alpha-tocopherol as an antioxidant. FEBS Lett 2000; 473:145-148.
32. Huie RE, Padmaja S: The reaction of NO with superoxide. Free Radic Res Commun 1993; 18: 195-199.
33. Ramasamy S, Drummond GR, Ahn J, et al: Modulation of expression of endothelial nitric oxide synthase by nordihydroguaiaretic acid, a phenolic antioxidant in cultured endothelial cells. Mol Pharmacol 1999; 56: 116-123.
34. Chen X, Touyz RM, Park JB, Schiffrin EL: Antioxidant effects of vitamins C and E are associated with altered activation of vascular NADPH oxidase an superoxide dismutase in stroke-prone SHR. Hypertension 2001; 38: 606-611.
35. Wagner AH, Schroeter MR, Hecker M: 17β-Estradiol inhibition of NADPH oxidase expression in human endothelial cells. FASEB J 2001; 15: 2121-2130.
36. Barchowsky A, Munro SR, Morana SJ, Vincenti MP, Treadwell M: Oxidant-sensitive and phosphorylation-dependent activation of NF-kappa B and AP-1 in endothelial cells. Am J Physiol 1995; 269: L829-L836.
37. Kyaw M, Yoshizumi M, Tsuchiya K, Kirima K, Tamaki T: Antioxidants inhibit JNK and p38 MAPK activation but not ERK1/2 activation by angiotensin II in rat aortic smooth muscle cells. Hypertens Res 2001; 24: 251-261.
38. Levites Y, Amit T, Youdim M, Mandel S: Involvement of protein kinase C activation and cell survival/cell cycle gene in green tea polyphenol (-)-epigallocatechin 3-gallate neuroprotective action. J Biol Chem 2002; 277: 30574-30580.
39. Lum H, Roebuck KA: Oxidant stress and endothelial cell dysfunction. Am J Physiol Cell Physiol 2001; 280: C719-C741.
40. Furumoto T, Saito N, Dong J, Mikami T, Fujii S, Kitabatake A: Association of cardiovascular risk factors and endothelial dysfunction in Japanese hypertensive patients: implication for early atherosclerosis. Hypertens Res 2002; 25: 475-480.
41. Lum H, Malik AB: Regulation of vascular endothelial barrier function. Am J Physiol Lung Cell Mol Physiol 1994; 267: L223-L241.
42. Suzuki H, Swei A, Zweifach BW, Schmid-Schonbein GW: In vivo evidence for microvascular oxidative stress in spontaneously hypertensive rats: hydroethidine microfluorography. Hypertension 1995; 25: 1083-1089.
43. Torrecillas G, Boyano-Adanez MC, Medina J, et al: The role of hydrogen peroxide in the contractile response to angiotensin II. Mol Pharmacol 2001; 59: 104-112..
44. Okayama N, Kevil CG, Correia L, et al: Nitric oxide enhances hydrogen peroxide-mediated endothelial permeability in vitro. Am J Physiol 1997; 273: C1581-1587.
45. Hamilton CA, Brosnan MJ, Al-Benna S, Berg G, Dominiczak AF: NAD(P)H oxidase inhibition improves endothelial function in rat and human blood. Hypertension 2002; 40: 755-762.